Scholarlink

Objective <p>To evaluate the association between the first-trimester ALU-PH index, calculated from routinely available laboratory parameters, and the subsequent development of preeclampsia.</p> Materials and methods <p>This retrospective case-control study included 206 singleton pregnancies followed at a tertiary referral center between January 2020 and December 2024. The study population comprised 98 women who subsequently developed preeclampsia and 108 normotensive controls. First-trimester laboratory parameters obtained between 11 and 13 + 6 weeks of gestation were used to calculate the ALU-PH index according to the formula: (AST × LDH × BUN) / (platelet × hemoglobin). Demographic, obstetric, and laboratory variables were compared between groups. Receiver operating characteristic (ROC) curve analysis was performed to assess the discriminatory performance of the ALU-PH index for predicting preeclampsia.</p> Results <p>Gestational age at delivery was significantly lower and 24-hour urinary protein excretion was significantly higher in the preeclampsia group than in the control group (both <i>p</i> &lt; 0.001). Among first-trimester laboratory parameters, AST levels were significantly higher in women who subsequently developed preeclampsia (18.26 ± 10.69 vs. 15.10 ± 7.31 U/L, <i>p</i> = 0.003), whereas the ALU-PH index was significantly lower in this group (15.46 ± 17.94 vs. 18.35 ± 17.00, <i>p</i> = 0.015). No significant differences were observed for maternal age, gravida, parity, BUN, LDH, platelet count, or hemoglobin levels. In ROC analysis, the ALU-PH index showed weak but statistically significant discriminatory performance for predicting preeclampsia, with an AUC of 0.598, sensitivity of 60.2%, specificity of 57.4%, and a cut-off value of 12.25.</p> Conclusion <p>The first-trimester ALU-PH index was significantly associated with subsequent preeclampsia; however, its discriminatory performance was weak and insufficient for standalone clinical use. The ALU-PH index may be considered an exploratory, low-cost adjunct marker, but prospective validation in larger and phenotype-stratified cohorts is required.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The use of the first trimester (AST × LDH × urea) / (platelet × hemoglobin) index in the prediction of preeclampsia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月24日

查看全文
  • Ali Çitirke,
  • Elif Işik,
  • Eda Büşra Babayiğit,
  • Fatma Doğa Öcal,
  • Dilek Şahin

摘要

Objective

To evaluate the association between the first-trimester ALU-PH index, calculated from routinely available laboratory parameters, and the subsequent development of preeclampsia.

Materials and methods

This retrospective case-control study included 206 singleton pregnancies followed at a tertiary referral center between January 2020 and December 2024. The study population comprised 98 women who subsequently developed preeclampsia and 108 normotensive controls. First-trimester laboratory parameters obtained between 11 and 13 + 6 weeks of gestation were used to calculate the ALU-PH index according to the formula: (AST × LDH × BUN) / (platelet × hemoglobin). Demographic, obstetric, and laboratory variables were compared between groups. Receiver operating characteristic (ROC) curve analysis was performed to assess the discriminatory performance of the ALU-PH index for predicting preeclampsia.

Results

Gestational age at delivery was significantly lower and 24-hour urinary protein excretion was significantly higher in the preeclampsia group than in the control group (both p < 0.001). Among first-trimester laboratory parameters, AST levels were significantly higher in women who subsequently developed preeclampsia (18.26 ± 10.69 vs. 15.10 ± 7.31 U/L, p = 0.003), whereas the ALU-PH index was significantly lower in this group (15.46 ± 17.94 vs. 18.35 ± 17.00, p = 0.015). No significant differences were observed for maternal age, gravida, parity, BUN, LDH, platelet count, or hemoglobin levels. In ROC analysis, the ALU-PH index showed weak but statistically significant discriminatory performance for predicting preeclampsia, with an AUC of 0.598, sensitivity of 60.2%, specificity of 57.4%, and a cut-off value of 12.25.

Conclusion

The first-trimester ALU-PH index was significantly associated with subsequent preeclampsia; however, its discriminatory performance was weak and insufficient for standalone clinical use. The ALU-PH index may be considered an exploratory, low-cost adjunct marker, but prospective validation in larger and phenotype-stratified cohorts is required.